Latest Strattera news
Many Patients Don’t Reach Target Dose of Atomoxetine
posted August 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
A considerable proportion of patients receiving atomoxetine (ATX), especially those receiving ATX monotherapy, do not reach the recommended dose of 80 mg/day, according to a study published online July 31 in CNS Neuroscience & Therapeutics.
Atomoxetine Use Doesn’t Up Suicide Risk in Children
posted April 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Treatment with the selective noradrenalin-reuptake-inhibitor atomoxetine is not associated with increased suicide risk compared with stimulant use in children and adolescents, according to a study published online April 26 in Pediatrics.
Insomnia Linked to Increased Risk for Stroke, Odds of Admission 
Age-Adjusted Suicide Rate Increased From 2014 to 2017 and Then Plateaued 
Air Pollution Tied to Higher Risk for Suicide 
Youth Suicide Risk Linked to Community Firearm Violence 
Better Youth Fitness May Lower Risk for Depression in Adulthood .jpg)
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder 
Childhood Cancer Survivors Often Have Mental Distress in Adulthood 
Reducing Ultraprocessed Food May Alleviate Symptoms of Depression Monthly Specialist Briefings
Stay Connected
